short analysis time of less than 10 min.11 Capillary HPLC coupled
with photoluminescence following electron transfer (PFET) offers
detection limits comparable to those of HPLC-EC and HPLC-FL
and overcomes the shortcomings associated with HPLC-CE (e.g.,
electrode fouling) and HPLC-FL (e.g., need for a pretreatment
step before sample injection).
In contrast to HPLC-CE, HPLC-FL and capillary HPLC-PFET,
in which analytes can only be identified by retention time
matching, LC/MS/MS can provide high specificity due to the
additional structure information obtained using tandem mass
spectrometric analysis. However, without a pretreatment step, LC/
MS/MS cannot offer adequate sensitivity for simultaneous mea-
surement of monoamines in rat brain microdialysates. A recently
reported LC/MS/MS-based assay by Hows and co-workers was
not able to determine basal levels of NE and 5-HT in rat brain
microdialysis due to its poor sensitivity.12
Chemical derivatization of amine groups on amino acids with
different chemical reagents has been shown to enhance amino
acid detection by ESI MS analysis.13-16 Differential isotopic
dimethyl labeling of N-terminal peptides with d(0)- and d(2)-, or
d(0), 12C-, and d(2), 13C-formaldehyde combined with LC-ESI or
LC-MALDI was used successfully in quantitative proteomics.17-20
N-Terminal dimethyl labeling was also reported for peptide
sequencing in combination with database searching and de novo
peptide sequencing of neuropeptides directly from tissue extract
without any genomic information.21-23 More recently, Guo and
co-workers reported an approach for quantitative profiling of
amine-containing metabolites in biological samples using LC-ESI
MS in conjunction with stable-isotope dimethyl labeling.24 The
labeling is carried out by using reductive amination chemistry.25
This chemical labeling has been reported to be simple, fast (less
than 10-min reaction time), specific, and provide high yields under
mild reaction conditions when used to label peptides and amine-
contained metabolites.17,24
the rat prefrontal cortex microdialysates following administration
of SKF-81297, a selective D1 dopamine receptor agonist known
to elevate the extracellular level of the neurotransmitter DA and
NE in the central nervous system.
EXPERIMENTAL SECTION
Chemicals and Reagents. (±)-Normetanephrine- R, ꢀ, ꢀ-d3
(d3-NM) HCl (98.7 atom % D), serotonin-a,a,b,b-d4 (d4-5-HT)
creatinine sulfate complex, and 2-(3,4-dihydroxyphenyl)ethyl-
1,1,2,2-d4-amine (d4-DA) HCl were purchased from C/D/N
Isotopes Inc. (Quebec, Canada). Sodium acetate, acetic acid,
ammonium acetate, HPLC-grade water, and methanol were
obtained from Mallinckrodt Becker (Phillipsburg, NJ). Formic acid
(96%) was analytical grade and obtained from Acros Organics.
Perfusion Fluid CNS was purchased from CMA Microdialysis Inc.
(North Chelmsford, MA). All other chemicals and reagents were
purchased from Sigma (St. Louis, MO) unless otherwise stated.
Reductive Amination. The derivatization of NE, DA, 5-HT,
and NM was adopted and modified from Guo et al.24 To profile
the derivatized monoamines, 10 µL of acetate buffer (1 M, pH 5)
and 20 µL of cyanoborohydride coupling buffer (containing 0.02
M sodium phosphate, pH 7.5, containing 0.2 M sodium chloride
and 3.0 g/L sodium cyanoborohydride) was added to four different
1.5-mL tubes, each containing 40 µL of 0.4 µg/mL NE, DA, 5HT,
and NM dissolved in HPLC-grade water, repectively. Then, the
mixture solution was vortexed and another 10 µL of 20% acetal-
dehyde-d4 was added to each tube. The final mixture solution was
vortexed and incubated at 37 °C for 25 min, followed by LC/MS
and LC/MS/MS analysis as described in the following sections.
To examine the effect of the concentration of cyanoborohydride
on the labeling efficiency, 0, 5, 10, 20, 30, and 40 µL of
cyanoborohydride coupling buffer were added into different wells
of a 96-well plate. Each well contained 30 µL of standard solution,
with a concentration of 1 ng/mL for each monoamine of interest,
which was prepared by diluting the stock solution using artificial
CSF/preservative solution (5 µM EDTA and 100 µM citric acid)
(5:1, v/v). Then the solution in each well was brought up to the
same volume by adding 35, 30, 20, 10, and 0 µL of artificial CSF/
preservative solution (5 µM EDTA and 100 µM citric acid) (5:1,
v/v), followed by the addition of 20 µL of 1 M acetate buffer and
10 µL of 25% acetaldehyde-d4. The resulted mixture was vortexed
and incubated at 37 °C for 25 min and finally analyzed using the
optimized LC-MRM method. To examine the effect of reaction
time on the labeling efficiency, 200 µL of freshly prepared labeling
reagent mixture was added into 300 µL of the same standard
solution that was used to check the effect of the concentration of
cyanoborohydride on the labeling efficiency. Then, the combined
solution was vortexed and incubated in the UPLC sample manage-
ment system, which had been set at 37 °C for 30 min before
conducting this experiment. The reaction solution was analyzed
using optimized UPLC-MRM method (see below) every 5 min
for 60 min. For the real sample analysis, to increase the
throughput, 25 µL of freshly prepared calibration standard solu-
tions, QC samples, and rat prefrontal cortex microdialysate
samples were added into different wells of a 96-well plate. Then,
10 µL of internal standard solution was added, followed by the
addition of 20 µL of freshly prepared labeling reagent mixture,
into each well containing standards, QCs, or rat prefrontal cortex
microdialysate samples. The resulting solutions in the 96-well plate
In this work, we report the successful combination of UPLC/
MS/MS with diethyl labeling of each primary amine group on
monoamine neurotransmitters, via reductive amination, for simul-
taneous measurement of a panel of monoamine neurotramitters
in rat prefrontal cortex microdialysates. A practical example of
the developed method is presented in which elevated levels of
NE, DA, and 5-HT, NM were detected over a 4.5-h time course in
(11) Jung, M. C.; Shi, G.; Borland, L.; Michael, A. C.; Weber, S. G. Anal. Chem.
2006, 78, 1755–1760
(12) Hows, M. E.; Lacroix, L.; Heidbreder, C.; Organ, A. J.; Shah, A. J. J. Neurosci.
Methods 2004, 138, 123–132
(13) Johnson, D. W. Rapid Commun. Mass Spectrom. 2001, 15, 2198–2205
(14) Liu, Z.; Minkler, P. E.; Lin, D.; Sayre, L. M. Rapid Commun. Mass Spectrom.
2004, 18, 1059–1065
(15) Qulrke, J. M. E.; Adams, C. L.; Van Berkel, G. J. Anal. Chem. 1994, 66,
1302–1315
(16) Yang, W. C.; Mirzaei, H.; Liu, X.; Regnier, F. E. Anal. Chem. 2006, 78,
4702–4708
(17) Hsu, J. L.; Huang, S. Y.; Chow, N. H.; Chen, S. H. Anal. Chem. 2003, 75,
6843–6852
(18) Ji, C.; Guo, N.; Li, L. J. Proteome Res. 2005, 4, 2099–2108
(19) Ji, C.; Li, L. J. Proteome Res. 2005, 4, 734–742
(20) Ji, C.; Li, L.; Gebre, M.; Pasdar, M.; Li, L. J. Proteome Res. 2005, 4, 1419–
1426
(21) Fu, Q.; Li, L. Anal. Chem. 2005, 77, 7783–7795
(22) Ji, C.; Lo, A.; Marcus, S.; Li, L. J. Proteome Res. 2006, 5, 2567–2576
(23) Hsu, J. L.; Huang, S. Y.; Shiea, J. T.; Huang, W. Y.; Chen, S. H. J. Proteome
Res. 2005, 4, 101–108
(24) Guo, K.; Ji, C.; Li, L. Anal. Chem. 2007, 79, 8631–8638
(25) Means, G. E.; Feeney, R. E. Biochemistry 1968, 7, 2192–2201
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
9196 Analytical Chemistry, Vol. 80, No. 23, December 1, 2008